COVID-19-Associated Hyperinflammation
Hyperinflammatory syndromes result from elevated levels of inflammatory biomarkers, such as interleukin (IL)-6, and are sometimes developed in patients with severe COVID-19. Some examples of hyperinflammatory syndromes are macrophage activation syndrome and cytokine release syndrome. Hyperinflammatory syndromes stem from cytokine storm syndromes and can lead to mortality and morbidity.
0
0
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Secondary Haemophagocytic Lymphiohistocytosis and COVID-19
Hyperinflammatory shock in children with family exposure to COVID-19
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19
Vascular Hyperpemeability and Multi-organ failure in COVID-19
Secondary haemophagocytic lymphohistiocytosis (sHLH) and COVID-19
Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Cytokine Release Syndrome and COVID-19
COVID-19-Associated Hyperinflammation